CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Viropro, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Viropro, Inc.
4199 Campus Drive, Suite 550
Phone: (917) 297-3674p:917 297-3674 IRVINE, CA  92612  United States Ticker: VPROVPRO
Business Summary
Viropro, Inc. is engaged in the development and manufacturing of biopharmaceutical drugs. The Company conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The Company intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201112/31/2010YesYes---

Industries
SIC Code Description
6794 Patent owners and lessors
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Interim Chairman of the Board Bruce A.Cohen 68 4/22/2016 6/2/2014
Chief Business Officer Jeffrey A.Hale 54 1/1/2012 8/1/2010
Director Michelle L.Peake 11/8/2013 10/19/2012
Director Ann H.Rose 10/19/2012 10/19/2012

Business Names
Business Name
Alpha Biologics Sdn
Alpha Biologics Sdn Bhd
Biologics Process Development Inc.
6 additional Business Names available in full report.

General Information
Number of Employees: 34 (As of 10/31/2011)
Outstanding Shares: 1,170,896,364 (As of 2/25/2014)
Shareholders: 541
Stock Exchange: OTC
Federal Tax Id: 133124057


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023